Genomics

Dataset Information

Salsalate improves the anti-tumor efficacy of Lenvatinib in MASH-driven hepatocellular carcinoma.


ABSTRACT: Salsalate improves the anti-tumor efficacy of Lenvatinib in MASH-driven hepatocellular carcinoma.

PROVIDER: PRJNA1189564 | ENA |

REPOSITORIES: ENA